| scholarly article | Q13442814 |
| P50 | author | Lance Johnson | Q79714953 |
| Jose M Arbones-Mainar | Q39940670 | ||
| P2093 | author name string | Raymond G Fox | |
| Hyung-Suk Kim | |||
| Nobuyo Maeda | |||
| Avani A Pendse | |||
| Michael K Altenburg | |||
| P2860 | cites work | A simple method for the isolation and purification of total lipides from animal tissues | Q25939009 |
| Apolipoprotein E: far more than a lipid transport protein | Q28204471 | ||
| Regulation of acetyl-CoA carboxylase | Q28302613 | ||
| Apo E structure determines VLDL clearance and atherosclerosis risk in mice. | Q30322098 | ||
| Differential modulation of diet-induced obesity and adipocyte functionality by human apolipoprotein E3 and E4 in mice | Q33585519 | ||
| Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association | Q33728882 | ||
| The role of the LDL receptor in apolipoprotein B secretion | Q33939089 | ||
| Clinical review 124: Diabetic dyslipidemia: causes and consequences | Q34174659 | ||
| Apolipoprotein E recycling: implications for dyslipidemia and atherosclerosis | Q36350929 | ||
| Genetic factors in diabetic nephropathy | Q36974103 | ||
| Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity. | Q51555624 | ||
| Influence of apo E phenotype on postprandial triglyceride and glucose responses in subjects with and without coronary heart disease. | Q51576055 | ||
| Liver carbohydrate and lipid metabolism of insulin-deficient mice is altered by trans-10, cis-12 conjugated linoleic acid. | Q54725694 | ||
| Association ofAPOEgenotype with carotid atherosclerosis in men and women | Q57337129 | ||
| Reversal of hypercholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor | Q64382900 | ||
| Targeted Replacement of the Mouse Apolipoprotein E Gene with the Common Human APOE3 Allele Enhances Diet-induced Hypercholesterolemia and Atherosclerosis | Q73500603 | ||
| ApoE epsilon2/epsilon3/epsilon4 polymorphism, ApoC-III/ApoE ratio and metabolic syndrome | Q80478902 | ||
| Apolipoprotein E polymorphism--a risk factor for metabolic syndrome | Q81233537 | ||
| Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions | Q37486465 | ||
| Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis | Q37548758 | ||
| Absence of hyperlipidemia in LDL receptor-deficient mice having apolipoprotein B100 without the putative receptor-binding sequences | Q37608495 | ||
| Apolipoprotein E4 in macrophages enhances atherogenesis in a low density lipoprotein receptor-dependent manner | Q37612769 | ||
| Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency | Q38292966 | ||
| Protection from obesity in mice lacking the VLDL receptor | Q38296977 | ||
| A self-contained 48-well fatty acid oxidation assay | Q40565825 | ||
| Apolipoprotein E: structure-function relationships | Q40737965 | ||
| ApoE isoform-dependent changes in hippocampal synaptic function | Q41519066 | ||
| Fatty acid regulation of very low density lipoprotein production | Q41521188 | ||
| Human LDL receptor enhances sequestration of ApoE4 and VLDL remnants on the surface of hepatocytes but not their internalization in mice | Q42327899 | ||
| Harmful effects of increased LDLR expression in mice with human APOE*4 but not APOE*3. | Q44582249 | ||
| Obesity modulates the association among APOE genotype, insulin, and glucose in men. | Q44705316 | ||
| Hepatic secretion of small lipoprotein particles in apobec-1-/- mice is regulated by the LDL receptor. | Q44897933 | ||
| Apolipoprotein e4 allele is predictor of coronary artery disease death in elderly patients with type 2 diabetes mellitus | Q44928858 | ||
| Defective VLDL metabolism and severe atherosclerosis in mice expressing human apolipoprotein E isoforms but lacking the LDL receptor | Q45079596 | ||
| Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice | Q45120387 | ||
| Effects of diabetes and CETP expression on diet-induced atherosclerosis in LDL receptor-deficient mice. | Q45241682 | ||
| Identification of apolipoprotein B-100 low density lipoproteins, apolipoprotein B-48 remnants, and apolipoprotein E-rich high density lipoproteins in the mouse. | Q46035244 | ||
| Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia | Q46345830 | ||
| apoE4 allele and the natural history of cardiovascular risk factors | Q46381127 | ||
| Multiple pathways of apolipoprotein E signaling in primary neurons | Q46386555 | ||
| Decreased lipoprotein clearance is responsible for increased cholesterol in LDL receptor knockout mice with streptozotocin-induced diabetes | Q46696587 | ||
| Overproduction of large VLDL particles is driven by increased liver fat content in man. | Q46931621 | ||
| The transport of triglycerides through the secretory pathway of hepatocytes is impaired in apolipoprotein E deficient mice | Q47926062 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| dyslipidemia | Q66291209 | ||
| P1104 | number of pages | 10 | |
| P304 | page(s) | 2285-2294 | |
| P577 | publication date | 2011-08-01 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | Apolipoprotein E4 exaggerates diabetic dyslipidemia and atherosclerosis in mice lacking the LDL receptor | |
| P478 | volume | 60 |
| Q38154771 | A possible structural basis behind the pathogenic role of apolipoprotein E hereditary mutations associated with lipoprotein glomerulopathy. |
| Q36538782 | Amelioration of Metabolic Syndrome-Associated Cognitive Impairments in Mice via a Reduction in Dietary Fat Content or Infusion of Non-Diabetic Plasma. |
| Q36843340 | ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesis |
| Q87289574 | Apolipoprotein E Epsilon 4 Enhances the Association between the rs2910164 Polymorphism of miR-146a and Risk of Atherosclerotic Cerebral Infarction |
| Q36201919 | Apolipoprotein E4 impairs macrophage efferocytosis and potentiates apoptosis by accelerating endoplasmic reticulum stress |
| Q50035045 | Apolipoprotein E4 mediates insulin resistance-associated cerebrovascular dysfunction and the post-prandial response |
| Q34759070 | CNF1 increases brain energy level, counteracts neuroinflammatory markers and rescues cognitive deficits in a murine model of Alzheimer's disease |
| Q42830359 | Effects of adipocyte-secreted factors on decidualized endometrial cells: modulation of endometrial receptivity in vitro |
| Q37645475 | Expression of human apolipoprotein E4 reduces insulin-receptor substrate 1 expression and Akt phosphorylation in the ageing liver |
| Q57817035 | Hyperglycemia Aggravates Diet-Induced Coronary Artery Disease and Myocardial Infarction in SR-B1-Knockout/ApoE-Hypomorphic Mice |
| Q33913173 | Polymerase I and transcript release factor (PTRF) regulates adipocyte differentiation and determines adipose tissue expandability. |
| Q37489258 | Reduced phosphorylation of brain insulin receptor substrate and Akt proteins in apolipoprotein-E4 targeted replacement mice. |
| Q38176761 | The E. coli CNF1 as a pioneering therapy for the central nervous system diseases |
| Q36462050 | Thermodynamic and structural destabilization of apoE3 by hereditary mutations associated with the development of lipoprotein glomerulopathy |
| Q57476233 | Thermodynamic destabilization and aggregation propensity as the underlying mechanism behind the genetic association of apoE3 mutants and Lipoprotein Glomerulopathy |
| Q51735096 | γ-Secretase Inhibition Lowers Plasma Triglyceride-Rich Lipoproteins by Stabilizing the LDL Receptor. |
Search more.